Aim:This retrospective study aims to analyze ten years of data on Psoriatic arthritis (PsA) patients treated at a single center in Abu Dhabi.Methodology:A retrospective study was conducted at a single center in Abu Dhabi, analyzing ten years of data on PsA patients.Demographic information, immunological assessments, medication history, and comorbidities were evaluated.Statistical analyses were performed using descriptive statistics and non-parametric methods.Results:The study included 49 PsA patients, predominantly Emirati (63.26%).Immunologic assessments demonstrated a significant decrease in Disease Activity in Psoriatic Arthritis score over time (p < 0.0001), along with improvements in inflammatory markers.Methotrexate was the most used medication (73.46%).Comorbidities such as hypertension (40.82%) and Type 2 diabetes mellitus (30.61%) were prevalent, while serious cardiovascular events and malignancy were rare. Conclusion:The study findings align with international guidelines, emphasizing the need for comprehensive management addressing various clinical domains.Despite limitations such as the retrospective design and small sample size, the study contributes to understanding PsA epidemiology and treatment patterns in the Middle East region.
No takes yet. Share an insight, caveat, or question.
A 2024 study studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: